Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy

AIDS. 2002 Apr 12;16(6):934-7. doi: 10.1097/00002030-200204120-00018.

Abstract

A total of 351 determinations of sexual hormones were carried out in 189 HIV-infected men in stable clinical condition. Highly active antiretroviral therapy (HAART) was associated with increased levels of both testosterone and 17beta-estradiol, but not with luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Protease inhibitors were more associated with testosterone, and non-nucleoside reverse transcriptase inhibitors with 17beta-estradiol. The values of both hormones, but not those of LH and FSH, increased with respect to pre-treatment levels in those patients who initiated HAART.

MeSH terms

  • Antiretroviral Therapy, Highly Active* / adverse effects
  • Estradiol / blood*
  • Follicle Stimulating Hormone / blood
  • HIV Infections / blood*
  • HIV Infections / drug therapy*
  • Humans
  • Luteinizing Hormone / blood
  • Male
  • Testosterone / blood*

Substances

  • Testosterone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone